Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0000899243-16-017489

Options or other derivatives

  • Chief Commercial Officer acquired 79,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Secor Alicia · Chief Commercial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2016-03-31 Grant or award : show line 1 in the form Stock Option (Right to Buy) −53,000 53,000 D
2016-03-31 Grant or award : show line 2 in the form Stock Option (Right to Buy) −26,500 26,500 D
Loading xslF345X03/doc4.xml…